Hospital at Home (HAH) for palliative care: an evaluatio
Completed
- Conditions
- Symptoms and general pathology: PainNot Applicable
- Registration Number
- ISRCTN75865015
- Lead Sponsor
- Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 229
Inclusion Criteria
1. 186 palliative care patients allocated to HAH and 43 palliative control patients. Comparison between HAH and standard care including both primary and secondary NHS input
2. Survey: 78 community nurses, 136 GPs. Assessment of community care only
3. Record linkage: 121 cancer patients referred to HAH, 206 cancer patients not referred to HAH. Both primary and secondary NHS input included
4. Longitudinal study: 54 lung cancer patients, 46 colorectal cancer patients. Both primary and secondary NHS input included.
Exclusion Criteria
Does not match inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Randomised controlled trial: place of death, rated symptom severity and adequacy of care, GP visits, care input from NHS primary and secondary care services during the last two weeks of life<br>2. Survey: ratings of the importance, benefits and disadvantages of HAH<br>3. Record linkage: demographic and clinical variables (age, sex, socio-economic status, survival, diagnosis, cause of death), service input variables (contact with oncology services, amount and start date of primary and secondary care NHS input in the last year of life)<br>4. Longitudinal study: prospective and retrospective expressed need and satisfaction with care, activities of daily living, contacts with health professionals, standard measures of health and quality of life (SF-36, EORTC QLQ-C30), and carer strain (CADI)
- Secondary Outcome Measures
Name Time Method ot provided at time of registration